ProAssurance (PRA) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
26 Jun, 2026Company overview and business model
Operated as a Delaware corporation with principal offices in Birmingham, Alabama.
Became a wholly owned subsidiary of The Doctors Company following a merger completed on June 26, 2026.
Offering details and pricing
All offerings of securities under the registration statement have been terminated as a result of the merger.
Unsold securities registered under the statement have been deregistered as of June 26, 2026.
Key takeaways
The company ceased independent public offerings due to acquisition and subsequent merger.
Registration statement amended to reflect deregistration of unsold securities.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ProAssurance
- Q1 2026 net income rose to $8.5M as merger closing nears and operating results improved.PRA
Q1 2026 - 2025 net income reached $50.9M, with improved ratios and a pending merger expected to close in 2026.PRA
Q4 2025 - Shareholders to vote on $25.00/share cash merger, board recommends approval, closing expected 2026.PRA
Proxy Filing - Director elections, auditor ratification, and say-on-pay highlight a performance-driven, well-governed agenda.PRA
Proxy Filing - Shareholders to vote on $25.00 per share cash merger; board unanimously recommends approval.PRA
Proxy Filing - ProAssurance to be acquired by The Doctors Company in a $1.3B deal, closing first half 2026.PRA
Proxy Filing - Q3 2024 net income rose to $16.4M as underwriting and investment results improved.PRA
Q3 2024 - Net income rose 45.9% to $15.5M as investment income surged and NORCAL gain was recognized.PRA
Q2 2024 - Operating and net income rose, with higher book value and strong investment returns.PRA
Q4 2024